In the same way, it turned out that miR-29c knockdown increased cellular drug resistance whereas miR-29c upregulation improved NSCLC cells’ sensitivity to DDP, this difference was linked to miR-29c’s modulation of the PI3K/Akt pathway (71). Here, AKT1 is linked to non-small cell lung carcinoma.